Trials / Completed
CompletedNCT02026882
Supreme LMA Use in Urgent Caesarean Section
Supreme Laryngeal Mask Use in Urgent Caesarean Section
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 584 (actual)
- Sponsor
- QuanZhou Women and Children's Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The Supreme Laryngeal Mask Airway (SLMA) is a single use supraglottic device that provides a good seal for positive pressure ventilation and good first attempt insertion rate of 98% in low risk patients undergoing elective Caesarean section. It has a double aperture design that facilitates the introduction of an orogastric tube to aspirate gastric contents. The primary study hypothesis is the first attempt insertion success rate of SLMA use in urgent Caesarean section.
Detailed description
Investigators propose a prospective cohort study to study the first attempt insertion success rate of supreme LMA in general anaesthesia for urgent caesarean section.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Supreme Laryngeal Mask Airway | Supreme Laryngeal Mask Airway. Preoxygenation, rapid sequence induction and cricoid pressure. Induction of general anaesthesia. |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2014-12-01
- Completion
- 2015-05-01
- First posted
- 2014-01-03
- Last updated
- 2020-08-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02026882. Inclusion in this directory is not an endorsement.